Wikidata

(Q34549807)

English

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

scientific article

In more languages

Statements

title
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
author name string
Steven Knapper
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Alan K Burnett
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Tim Littlewood
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
W Jonathan Kell
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Sam Agrawal
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Richard Clark
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Mark J Levis
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
Donald Small
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017
page(s)
3262-3270
1 reference
stated in
Europe PubMed Central
PubMed ID
16857985
retrieved
3 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34549807&oldid=1987583231"